This rebound effect occurs because the amylin receptor system, having adapted to sustained agonism, temporarily overcompensates when that stimulation is removed
It belongs to a novel class of agents known as triple incretin receptor agonists, meaning it simultaneously activates three distinct hormone receptors: the glucagon-like peptide-1 (GLP-1) receptor, the glucose-dependent insulinotropic polypeptide (GIP) receptor, and the glucagon receptor
Pharm) on April 23, 2025
There was no statistically significant adjusted difference in sex life (12.7, 95% CI 0.7 to 26.0) and public distress (9.3, 95% CI 1.9 to 20.4) between groups
Comprehensive cardiometabolic improvements were observed including reductions in waist circumference, blood pressure, lipids, uric acid, liver fat content, and hepatic transaminases